Use of advanced systemic therapy in adolescent patients with moderate-to-severe atopic dermatitis in the TARGET-DERM Registry

Main Article Content

Michael Haft
Keith Knapp
a:1:{s:5:"en_US";s:10:"Target RWE";}

Ami Claxton
Breda Munoz
Sanjeev Balu
Shannon Schnieder
Jonathan Silverberg
Diamant Thaci
Lawrence Eichenfield

Keywords

Atopic Dermatitis, Registry, Target RWE, Advanced Systemic Therapy, vIGA-AD, Treatment, Naive, POEM, BSA

References

1. Nutten, S., Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab, 2015. 66 Suppl 1: p. 8-16.

2. AD Langan SM, Irvine AD, Weidinger S. Lancet. 2020 Aug 1;396(10247):345-360.

3. Abuabara, K. International observational atopic dermatitis cohort to follow natural history and treatment course: TARGETDERM AD study design and rational BMJ Open 2020;10:e0399282020.

Article Sidebar

Poster PDF
Published
Mar 13, 2023
DOI https://doi.org/10.25251/skin.7.supp.149

Article Details

How to Cite
[1]
Haft, M., Knapp, K., Claxton, A., Munoz, B., Balu, S., Schnieder, S., Silverberg, J., Thaci, D. and Eichenfield, L. 2023. Use of advanced systemic therapy in adolescent patients with moderate-to-severe atopic dermatitis in the TARGET-DERM Registry. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s149. DOI:https://doi.org/10.25251/skin.7.supp.149.
Issue
Vol. 7 No. 2 (2023): March Issue & Poster Presentations from WCH23 Dermatology Conference®
Section
Atopic Dermatitis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>